Provided by Tiger Trade Technology Pte. Ltd.

ZYMEWORKS INC (US)

29.41
+1.144.03%
Pre-market: 29.26-0.1500-0.51%05:32 EDT
Volume:716.49K
Turnover:20.92M
Market Cap:2.09B
PE:-14.56
High:29.70
Open:28.06
Low:27.81
Close:28.27
52wk High:30.62
52wk Low:13.60
Shares:70.96M
Float Shares:66.05M
Volume Ratio:0.68
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0200
EPS(LYR):-1.0800
ROE:-72.31%
ROA:-24.14%
PB:25.97
PE(LYR):-27.23

Loading ...

Analysts Offer Insights on Healthcare Companies: Perrigo Company (PRGO) and Zymeworks (ZYME)

TIPRANKS
·
Jun 09

Zymeworks Price Target Maintained With a $46.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 03

Zymeworks files Form 3 for EVP, General Counsel Paul R. Schneider

Reuters
·
May 16

Zymeworks authorizes share repurchase program of up to $125M

TIPRANKS
·
May 15

Zymeworks Announces Share Repurchase Program of up to $125 Million of Its Common Stock

THOMSON REUTERS
·
May 15

Zymeworks management to join Stifel Virtual Targeted Oncology Forum fireside chat

Reuters
·
May 13

Citi Reaffirms Their Buy Rating on Zymeworks (ZYME)

TIPRANKS
·
May 10

Zymeworks Down Over 9%, on Pace for Largest Percent Decrease Since December 2022 -- Data Talk

Dow Jones
·
May 09

Zymeworks (ZYME) Gets a Buy from Wells Fargo

TIPRANKS
·
May 08

Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Thermo Fisher (TMO) and Claritev (CTEV)

TIPRANKS
·
May 08

Zymeworks Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 08

Canada's Zymeworks Q1 revenue misses estimates on absence of prior milestone payments

Reuters
·
May 08

Zymeworks Q1 EPS $(0.59) Down From $(0.30) YoY, Sales $2.408M Down From $27.110M YoY

Benzinga Earnings
·
May 08

Zymeworks Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 06

Earning Preview: ZYMEWORKS INC (US) revenue is expected to decrease by 21.26%, institutional views are bullish

Earnings Agent
·
Apr 30

April 2026's Top 3 Stocks That May Be Trading Below Estimated Fair Value

Simply Wall St.
·
Apr 28

Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF), Zymeworks (ZYME) and Definium Therapeutics (DFTX)

TIPRANKS
·
Apr 23

Zymeworks (ZYME) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Apr 22

A Look At Zymeworks (ZYME) Valuation As AACR 2026 ADC Data Draws Investor Attention

Simply Wall St.
·
Apr 20

Zymeworks to present Phase 1 ZW191 dose-escalation data at AACR 2026

Reuters
·
Apr 18